NCT00530790View on ClinicalTrials.gov

Clinical Evaluation of Ropinirole CR-RLS ( SK&F101468)Tablets in Restless Legs Syndrome

PHASE2CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

August 23, 2007

Primary Completion Date

February 1, 2008

Study Completion Date

February 1, 2008

Conditions
Restless Legs Syndrome
Interventions
DRUG

ropinirole controlled release (CR)-RLS

White film-coated round-shaped tablet

Trial Locations (11)

802-0084

GSK Investigational Site, Fukuoka

810-0044

GSK Investigational Site, Fukuoka

830-0011

GSK Investigational Site, Fukuoka

733-0031

GSK Investigational Site, Hiroshima

210-0024

GSK Investigational Site, Kanagawa

550-0004

GSK Investigational Site, Osaka

589-0022

GSK Investigational Site, Osaka

599-8263

GSK Investigational Site, Osaka

321-0293

GSK Investigational Site, Tochigi

151-0053

GSK Investigational Site, Tokyo

187-0041

GSK Investigational Site, Tokyo

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY